Remove 2019 Remove Diagnosis Remove Government Remove Relationship
article thumbnail

District Court Interprets EKRA

FDA Law

S&G Labs alleged during the litigation that they are paid on a “per test” basis by third party insurers, government agencies under the Medicare and Medicaid programs, and direct “self-pay” by some individuals. S&G Labs has no contractual relationships with the entities that referred clients to S&G Labs. Graves , 2021 U.S.

article thumbnail

District Court Interprets EKRA

FDA Law

S&G Labs alleged during the litigation that they are paid on a “per test” basis by third party insurers, government agencies under the Medicare and Medicaid programs, and direct “self-pay” by some individuals. S&G Labs has no contractual relationships with the entities that referred clients to S&G Labs. Graves , 2021 U.S.

article thumbnail

The Promise and Pitfalls of AI in Medicine: Guest Bob Wachter

GeriPal

Alex: In 2019 … You wrote two viewpoints about AI recently in JAMA, relatively recently. I guess, 2019, and then, one again about last month or so. And what I want to do is, this is a tough task for you, I’m sure, but I have a patient with a new diagnosis of cancer, and it’s actually a 35-year-old woman.

IT 139